Private Advisor Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.97M | Buy |
50,035
+4,010
| +9% | +$562K | 0.03% | 511 |
|
|
2025
Q4 | $5.65M | Buy |
46,025
+1,442
| +3% | +$175K | 0.03% | 577 |
|
|
2025
Q3 | $4.95M | Buy |
44,583
+2,069
| +5% | +$235K | 0.02% | 627 |
|
|
2025
Q2 | $4.71M | Buy |
42,514
+4,239
| +11% | +$451K | 0.03% | 591 |
|
|
2025
Q1 | $4.29M | Buy |
38,275
+3,593
| +10% | +$371K | 0.03% | 594 |
|
|
2024
Q4 | $3.2M | Sell |
34,682
-2,964
| -8% | -$267K | 0.02% | 686 |
|
|
2024
Q3 | $3.16M | Sell |
37,646
-5,794
| -13% | -$442K | 0.02% | 685 |
|
|
2024
Q2 | $2.98M | Sell |
43,440
-1,055
| -2% | -$70.4K | 0.02% | 680 |
|
|
2024
Q1 | $3.26M | Sell |
44,495
-10,015
| -18% | -$770K | 0.02% | 613 |
|
|
2023
Q4 | $4.42M | Buy |
54,510
+1,525
| +3% | +$119K | 0.03% | 472 |
|
|
2023
Q3 | $3.97M | Sell |
52,985
-3,251
| -6% | -$250K | 0.04% | 470 |
|
|
2023
Q2 | $4.31M | Buy |
56,236
+1,871
| +3% | +$149K | 0.04% | 449 |
|
|
2023
Q1 | $4.51M | Sell |
54,365
-2,763
| -5% | -$229K | 0.04% | 410 |
|
|
2022
Q4 | $2.53M | Buy |
57,128
+3,657
| +7% | +$290K | 0.13% | 171 |
|
|
2022
Q3 | $3.3M | Sell |
53,471
-26,924
| -33% | -$1.7M | 0.04% | 451 |
|
|
2022
Q2 | $4.97M | Buy |
80,395
+2,974
| +4% | +$184K | 0.04% | 411 |
|
|
2022
Q1 | $4.6M | Sell |
77,421
-20,206
| -21% | -$1.29M | 0.04% | 479 |
|
|
2021
Q4 | $7.09M | Sell |
97,627
-42,110
| -30% | -$2.9M | 0.05% | 347 |
|
|
2021
Q3 | $9.76M | Buy |
139,737
+56,904
| +69% | +$4M | 0.06% | 307 |
|
|
2021
Q2 | $5.7M | Buy |
82,833
+2,064
| +3% | +$138K | 0.05% | 363 |
|
|
2021
Q1 | $5.22M | Buy |
80,769
+10,119
| +14% | +$652K | 0.05% | 363 |
|
|
2020
Q4 | $4.12M | Buy |
70,650
+14,157
| +25% | +$854K | 0.04% | 392 |
|
|
2020
Q3 | $3.86M | Sell |
56,493
-7,279
| -11% | -$505K | 0.05% | 352 |
|
|
2020
Q2 | $4.91M | Buy |
63,772
+6,627
| +12% | +$508K | 0.07% | 271 |
|
|
2020
Q1 | $4.27M | Buy |
57,145
+18,371
| +47% | +$1.27M | 0.08% | 254 |
|
|
2019
Q4 | $2.52M | Sell |
38,774
-30,202
| -44% | -$1.97M | 0.04% | 454 |
|
|
2019
Q3 | $4.41M | Buy |
68,976
+20,199
| +41% | +$1.32M | 0.07% | 291 |
|
|
2019
Q2 | $3.29M | Sell |
48,777
-5,747
| -11% | -$378K | 0.06% | 331 |
|
|
2019
Q1 | $3.53M | Sell |
54,524
-1,897
| -3% | -$126K | 0.07% | 287 |
|
|
2018
Q4 | $3.52M | Sell |
56,421
-13,947
| -20% | -$975K | 0.08% | 248 |
|
|
2018
Q3 | $5.43M | Buy |
70,368
+32,681
| +87% | +$2.47M | 0.11% | 191 |
|
|
2018
Q2 | $2.68M | Sell |
37,687
-15,834
| -30% | -$1.12M | 0.04% | 214 |
|
|
2018
Q1 | $4.04M | Buy |
53,521
+17,630
| +49% | +$1.4M | 0.16% | 146 |
|
|
2017
Q4 | $2.66M | Sell |
35,891
-50,170
| -58% | -$3.81M | 0.11% | 183 |
|
|
2017
Q3 | $7.05M | Buy |
86,061
+5,252
| +6% | +$402K | 0.17% | 129 |
|
|
2017
Q2 | $5.6M | Buy |
80,809
+1,268
| +2% | +$84.4K | 0.15% | 152 |
|
|
2017
Q1 | $5.29M | Sell |
79,541
-10,581
| -12% | -$744K | 0.15% | 156 |
|
|
2016
Q4 | $6.65M | Buy |
90,122
+8,208
| +10% | +$610K | 0.22% | 106 |
|
|
2016
Q3 | $6.33M | Sell |
81,914
-578
| -0.7% | -$47K | 0.26% | 92 |
|
|
2016
Q2 | $7.05M | Buy |
82,492
+10,317
| +14% | +$916K | 0.29% | 85 |
|
|
2016
Q1 | $6.61M | Sell |
72,175
-16,727
| -19% | -$1.51M | 0.32% | 69 |
|
|
2015
Q4 | $9M | Buy |
88,902
+6,498
| +8% | +$676K | 0.43% | 48 |
|
|
2015
Q3 | $8.09M | Buy |
82,404
+6,257
| +8% | +$695K | 0.44% | 48 |
|
|
2015
Q2 | $8.91M | Buy |
76,147
+4,271
| +6% | +$467K | 0.42% | 46 |
|
|
2015
Q1 | $7.05M | Buy |
71,876
+25,377
| +55% | +$2.58M | 0.41% | 50 |
|
|
2014
Q4 | $4.38M | Buy |
46,499
+8,621
| +23% | +$892K | 0.28% | 82 |
|
|
2014
Q3 | $4.03M | Buy |
37,878
+6,344
| +20% | +$621K | 0.28% | 81 |
|
|
2014
Q2 | $2.61M | Buy |
31,534
+2,668
| +9% | +$208K | 0.22% | 96 |
|
|
2014
Q1 | $2.04M | Buy |
28,866
+9,178
| +47% | +$720K | 0.22% | 107 |
|
|
2013
Q4 | $1.48M | Buy |
+19,688
| New | +$1.37M | 0.17% | 148 |
|
Other funds holding GILD
VCM
VPM
Private Advisor Group's GILD Position: Q1 2026 in Review
Private Advisor Group increased its Gilead Sciences (GILD) stake by 8.7% in Q1 2026, buying an estimated $562K and bringing the position to 50,035 shares worth $6.97M. The position accounts for 0.03% of the portfolio, ranked #511.
Private Advisor Group first reported a position in GILD in Q4 2013 and has held it in 50 quarters since. The position peaked at $9.76M in Q3 2021. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Private Advisor Group held 50,035 shares of Gilead Sciences worth $6.97M as of Q1 2026.
- Private Advisor Group bought 4,010 Gilead Sciences shares in Q1 2026, an estimated $562K.
- Gilead Sciences made up 0.03% of Private Advisor Group's portfolio in Q1 2026, its #511 holding.
- Private Advisor Group first reported a position in Gilead Sciences in Q4 2013 and has held it in 50 quarters since.
- Private Advisor Group's Gilead Sciences position peaked at $9.76M in Q3 2021.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Private Advisor Group's 13F filing for Q1 2026, filed 27 Apr 2026.